CANOC Publications
October, 2015 - BMC Infectious Diseases
Factors associated with the frequency of monitoring of liver enzymes, renal function and lipid laboratory markers among individuals initiating combination antiretroviral therapy: a cohort study
Jennifer Gillis, Ahmed M Bayoumi, Ann N Burchell, Curtis Cooper, Marina B Klein, Mona Loutfy, Nima Machouf, Julio SG Montaner, Chris Tsoukas, Robert S Hogg, Janet Raboud, and The Canadian Observational Cohort (CANOC) Collaboration.
Plain Language Summary PDFOctober, 2015 - J Int AIDS Soc
Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care
Angela Cescon, Sophie Patterson, Colin Davey,Erin Ding, Janet M Raboud, Keith Chan, Mona R Loutfy, Curtis Cooper, Ann N Burchell, Alexis K Palmer, Christos Tsoukas, Nima Machouf, Marina B Klein, Sean B Rourke, Anita Rachlis, Robert S Hogg, Julio SG Montaner, and the CANOC Collaboration*
Plain Language Summary PDFJuly, 2015 - BMC Infect Dis
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
Patterson S, Cescon A, Samji H, Chan K, Zhang W, Raboud J, Burchell AN, Cooper C, Raboud J, Klein MB, Rourke SB, Loutfy MR, Machouf N, Montaner JSG, Tsoukas C, Hogg RS; Canadian Observational Cohort (CANOC) Collaboration.
Plain Language Summary PDFSeptember, 2014 - HIV Med
Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada
Samji H, Taha T, Moore D, Burchell A, Cescon A, Cooper C, Raboud J, Klein M, Loutfy M, Machouf N, Tsoukas C, Montaner J, Hogg R; Canadian Observational Cohort (CANOC) Collaboration; Canadian Observational Cohort CANOC Collaboration.
Plain Language Summary PDFMarch, 2014 - J Int Assoc Provid AIDS Care
Impact of the Data Collection on Adverse Events of Anti-HIV Drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in Canada
Antoniou T, Gillis J, Loutfy MR, Cooper C, Hogg RS, Klein MB, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Raboud JM; Canadian Observational Cohort (CANOC) collaboration.
Plain Language Summary PDFMarch, 2014 - HIV Med
Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy
Ndumbi P, Gillis J, Raboud J, Cooper C, Hogg RS, Montaner JS, Burchell AN, Loutfy MR, Machouf N, Klein MB, Tsoukas C; Canadian Observational Cohort (CANOC) Collaboration.
Plain Language Summary PDFJanuary, 2014 - AIDS
Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history
Cescon A, Chan K, Raboud JM, Burchell AN, Forrest JI, Klein MB, Loutfy MR, Machouf N, Montaner JS, Tsoukas C, Hogg RS, Cooper C; CANOC Collaboration.
Plain Language Summary PDFJanuary, 2014 - J Int Assoc Provid AIDS Care
Factors Associated with Late Initiation of Highly Active Antiretroviral Therapy among Young HIV-Positive Men and Women Aged 18 to 29 Years in Canada
Palmer AK, Cescon A, Chan K, Cooper C, Raboud JM, Miller CL, Burchell AN, Klein MB, Machouf N, Montaner JS, Tsoukas C, Hogg RS, Loutfy MR; CANOC Collaboration.
Plain Language Summary PDFDecember, 2013 - PLoS One
Gender Differences in Clinical Outcomes among HIV-Positive Individuals on Antiretroviral Therapy in Canada: A Multisite Cohort Study
Cescon A, Patterson S, Chan K, Palmer AK, Margolese S, Burchell AN, Cooper C, Klein MB, Machouf N, Montaner JS, Tsoukas C, Hogg RS, Raboud JM, Loutfy MR; CANOC Collaboration.
Plain Language Summary PDFOctober, 2013 - PLoS One
Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy
Leung V, Gillis J, Raboud J, Cooper C, Hogg RS, Loutfy MR, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Klein MB; CANOC Collaboration.
Plain Language Summary PDF